Big News: FDA is moving from MasterControl to ComplianceQuest.See Why
Talk to a SpecialistLoading…
Talk to a SpecialistTalk to a SpecialistBased on limited metadata, this FDA Warning Letter issued to Strides Pharma Science Limited on July 1, 2019, concerns drug manufacturing or distribution practices. Without access to the full letter text or specific subject line, the exact nature of the violations cannot be determined from the available information. The warning falls under FDA's drug product oversight, though the specific issuing office is not identified in the metadata provided. To understand the particular compliance issues cited, the complete Warning Letter would need to be reviewed.